SUBOXONE BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE EQ 2MG BASE; EQ 0.5MG BASE TABLET;SUBLINGUAL Discontinued No ... U.S. Food and Drug Administration, 1 month ago
3 images for "Suboxone Tablets"
LONDON (Alliance News) - Indivior PLC on Friday raised its full-year guidance for 2016, as market share for its core Suboxone Film treatment for opioid dependence remained resilient. The pharmaceutical company, spun off from Reckitt Benckiser Group ...4 Traders, 4 weeks ago TOP NEWS: Indivior Raises Guidance As Suboxone Market Share Resilient London Stock Exchange, 4 weeks ago
In a change to the dismay of physicians and patients, Maryland's Medicaid program recently removed Suboxone film, a drug used in the treatment of opioid addiction, from the state's list of preferred drugs and substituted it with the tablet form ...Wolters Kluwer Law & Business, 4 weeks ago Maryland Switches Opioid Treatments, And Some Patients Cry Foul Northeast Indiana Public Radio, 1 month ago
Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays - Detailed analysis on Technologies and Pipeline Development
Within the oral mucosal cavity, the buccal region offers an attractive route of administration for systemic drug delivery. The mucosa has a rich blood supply and it is relatively permeable. The buccal mucosa offers several advantages for controlled ...MyNewsDesk, 1 month ago
Mundipharma has obtained exclusive global (ex-US) rights to Orexo's Zubsolv (buprenorphine and naloxone sublingual tablet), a potential new treatment option for patients outside the US with opioid dependence. Under the terms of the agreement, Orexo ...European Pharmaceutical Review, 1 month ago OREXO : Mundipharma obtains global ex-US rights to Zubsolv 4 Traders, 1 month ago Orexo: Mundipharma To Take Zubsolv Global Investing.com, 1 month ago Mundipharma AG Obtains Global (Ex-US) Rights To Orexo???s Opioid Dependence Treatment Zubsolv (Buprenorphine And Naloxone) BioSpace, 1 month ago
IntelGenx Corp. ( OTCQX:IGXT ) Q2 2016 Results Earnings Conference Call August 11, 2016 4:30 PM ET Executives Edward Miller - Director, IR Dr. Horst Zerbe - President and CEO Andre Godin - EVP and CFO Analysts Swayampakula ...Seeking Alpha, 2 weeks ago BioDelivery Sciences' (BDSI) CEO Mark Sirgo on Q2 2016 Results - Earnings Call Transcript Seeking Alpha, 2 weeks ago
The portfolio is a mix of six ANDAs pending approval, one approved ANDA and one ANDA with tentative approval, and comprises complex generic products across diverse dosage forms. August 11, 2016 By Denice Cabel Allergan Dr. Reddy's ...PharmaAsia, 2 weeks ago Dr Reddys Laboratories Ltd completes acquisition of product portfolio from TEVA Equity Bulls, 3 weeks ago Dr. Reddy's buys eight product ANDA portfolio from TEVA for undisclosed amount PredictWallStreet, 3 weeks ago Dr. Reddy 's Completes Acquisition of Product Portfolio from TEVA Stockwatch, 3 weeks ago
INDIVIOR PLC SPON ADR EA REPR 5 (NASDAQ:INVVY) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a note issued to investors on Thursday. The brokerage currently has a $20.00 price objective on the stock. Zacks ...Zolmax News, 3 weeks ago Research Analysts Upgrades for July, 28th (ATVI, CALM, F, HMST, HURN, HZO, INVVY, IPAR, ISIL, JJSF) American Banking News, 4 weeks ago Zacks Investment Research Upgrades INDIVIOR PLC SPON ADR EA REPR 5 (INVVY) to Buy American Banking News - Forex, 4 weeks ago
More from: , Mideast Time...and 2 other sources
J uly 28, 2016 [embedded content] By Dr. Mercola While most drugs come with a long list of potentially devastating side effects, painkillers — courtesy of their addictive nature — tend to be among the most lethal. have risen by 300 ...Before It's News, 4 weeks ago
Michele Maatouk (ShareCast News) - FTSE 250 specialty pharmaceuticals firm Indivior lifted its full-year guidance on Friday as it reported a rise in first-half net sales. For the half to 30 June, net revenue rose to $531m from $517m in the same ...BullBearings, 4 weeks ago
on your WebpageAdd Widget >Get your members hooked!